# FDA recall D-1082-2020

> **PharMEDium Services, LLC** · Class II · drug recall initiated 2020-03-16.

## Product

nICARdipine HCl (0.1 mg/mL) 1 mg/10mL,  in 0.9% Sodium Chloride Injection USP, 10 ml in a 20mL syringe, Rx Only, PharMEDium Services LLC 12620 W. Airport Boulevard #130 Sugar Land, TX 77470. NDC 71019-206-01

## Reason for recall

Firm is recalling 46 lots of various products because of a lack of sterility assurance.

## Distribution

Distributed Nationwide in the US

## Key facts

- **Recall number:** D-1082-2020
- **Recalling firm:** PharMEDium Services, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-03-16
- **Report date:** 2020-04-15
- **Termination date:** 2025-02-14

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Dayton, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1082-2020

## Citation

> AI Analytics. FDA recall D-1082-2020. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-1082-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*